QKS Logo
QKS Library Icon

QKS Library

NewsroomSPARK Plus™Sign In
QKS Logo

Validate the growth strategy before you fund it.

An analyst engagement for the CEO and CMO — your growth assumptions tested against evidence from the market you sell into, with the verdict delivered straight, whichever way it points.

Six GRI pillars

The Go-to-Market Readiness Index

Hypothesis-driven

Every assumption carries a falsification test

Evidence, graded

Independent sources outweigh assertion — always

Analyst-led

Run by the analysts who rate your category

THE PROBLEM

Why most GTM strategies fail

Market Expansion

Messaging

Pricing

Sales Hiring

Pipeline

Revenue Miss

The most expensive GTM mistake is funding the wrong strategy.

Most GTM failures are not execution failures — they originate from unvalidated strategic assumptions. Companies fund sales teams, campaigns, and partner ecosystems before anyone independently tests whether the underlying strategy is correct. By the time the revenue miss surfaces, the flawed assumption is buried under two years of execution built on top of it. The validation belongs before the investment.

TYPICAL ENGAGEMENTS

When vendors come to us

Market expansion

The entry plan is built; nobody has independently tested whether the segment is what the plan assumes.

New product launch

Positioning, pricing, and ICP are set — validate them before the launch budget is committed.

GTM transformation

Features added alongside the product. A copilot in a sidebar, a summarizer, a chat box. The workflow underneath is unchanged.

Investor due diligence

Decisioning at scale, with the explainability and control an enterprise can actually deploy. Autonomy without governance is a demo, not a product.

THE FRAMEWORK

Six hypotheses every growth strategy must survive

The six GRI pillars — each one a hypothesis your strategy currently treats as settled. In the engagement, each is tested against evidence; in the scorecard, each carries the same name you see here.

HYPOTHESIS 01

Market & Growth

Is the market you've chosen the market that's actually there — size, growth, and timing?

HYPOTHESIS 02

Customer & Demand

Does the buyer you sell to, and the problem you solve, match what demand-side evidence shows?

HYPOTHESIS 03

Offering & Portfolio

Does the product story hold against what buyers evaluate and what usage shows?

HYPOTHESIS 04

Positioning & Competitive

Do your differentiation claims survive contact with rivals' actual capability?

HYPOTHESIS 05

Commercial Model

Do pricing, packaging, and deal economics hold up in the cohort data?

HYPOTHESIS 06

Route-to-Market & Execution

Does the motion — direct, partner, product-led — perform the way the plan assumes?

THE METHODOLOGY

How a validation runs

Claims become hypotheses. Hypotheses meet evidence. What survives is scored; what doesn't is named.

01

Executive diagnostic

Structured interviews across business, product, marketing, and sales leadership capture how you believe your GTM works.

02

Claims register

Every strategic assumption documented and classified — the beliefs your plan is funding.

03

Hypothesis development

Each claim becomes testable, with a named condition that would prove it wrong.

04

Evidence validation

Tested against market intelligence, buyer research, competitive analysis, and your own commercial performance.

05

Strategic assessment

GTM health and right-to-win, measured across the six pillars.

06

Transformation roadmap

Recommendations prioritized by business impact, complexity, and urgency.

Executive Strategic Verdict — QKS Strategic Validation Engine

Every engagement runs on the same validation system — one methodology, one scoring discipline, engagement after engagement. Illustrative engagement shown; in this one, the verdict was 56/100 — at risk.

Every recommendation carries its evidence, its confidence score, and its rationale — not consulting opinion. If the evidence doesn't support a claim, the report says so.

DELIVERABLES

You leave with six artifacts

Executive Assessment Report

Your advisor maps where the estate stands — spend, coverage, overlap, and risk.

GTM Health Score

One defensible number across the six pillars — with the failed assumptions that cap it named.

Right-to-Win Assessment

Competitive readiness across the strategic dimensions that decide whether the market is winnable by you.

Strategic Risk Register

The critical assumptions that didn't survive validation — the ones requiring executive attention first.

Prioritized Recommendations

Each tied to the evidence that earned it, with an owner and a horizon: short, medium, long.

Executive Roadmap

The 90-day, 6-month, and 12-month sequence — what changes, in what order, and why that order.

WHY THIS VERDICT IS DIFFERENT

Validation against a standing body of evidence

Consulting research is built for the engagement. Our evidence base exists before your engagement begins — the analysts who validate your GTM rate your category, take your competitors' briefings, and hear enterprise buyers in inquiry. Every validation draws on that standing record:

COMPETITIVE EVIDENCE

SPARK Matrix™ evaluations

The standing assessment of every rated vendor in your category — including the ones you compete against.

COMPETITIVE EVIDENCE

Vendor briefings

Your rivals brief the same analysts — product, roadmap, wins, losses — cycle after cycle.

CUSTOMER EVIDENCE

Enterprise buyer inquiry

Why buyers shortlist, why they don't, and what they wish existed — from the demand side of QKS.

CUSTOMER EVIDENCE

VoC Resonance™

What users actually realize one year past purchase — versus what the category promised them.

MARKET EVIDENCE

Share models & forecasts

QKS-modeled market share and five-year forecasts across 300+ ICT markets — not vendor-reported figures.

ECONOMIC EVIDENCE

ROI Benchmark Framework™

The value and cost baselines enterprise buyers already use to check vendor claims.

WHO YOU'D WORK WITH

Validate your GTM with the experts who study markets, and the leaders who've grown them.

Divya Baranawal

Divya Baranawal

Vice President & Principal Analyst

Know more

Narayan Gokhale

Narayan Gokhale

Vice President & Principal Analyst

Know more

Umang Thakur

Umang Thakur

Vice President & Principal Analyst

Know more

Aaron Andrew

Aaron Andrew

Practice Director

Know more

Test the story before the market does.

Tell us the market you sell into and the decision ahead. We'll scope the validation.